Members |
targetComponentId |
Grafting of tarsal or metatarsal |
Grafting of phalanges of foot |
Grahamella |
Bartonella |
Grahamella peromysci |
Bartonella peromysci |
Grahamella species |
Bartonella |
Grahamella talpae |
Bartonella peromysci |
Grahamellosis |
Bartonellosis |
grampositiv, forgrenet, filamentøs hyphae |
Gram-positive branched filamentous bacilli present (finding) |
multiparitet med prænatalt problem |
Grand multipara |
patients bedsteforælder |
Grandparent |
Granuloma of lacrimal passages |
Lacrimal sac granuloma |
granulom i operationssår |
Granuloma of surgical wound (finding) |
granulovakuolær degeneration af typen Simchowicz |
Granulovacuolar degeneration |
Graphosid spider |
Order Araneae (organism) |
struktur af gravid uterus |
Uterine structure |
Gravida, ikke nærmere specificeret |
Gravida |
Gravida NOS |
Gravida |
Gray elder pollen |
Grey alder pollen |
Grease |
Automotive grease (substance) |
Great toe flap |
Flap (substance) |
Great vessel repair with unlisted major procedure |
Repair of great vessels |
grøn farve |
Green color (qualifier value) |
Greenfield-filter |
Vena cava filter (physical object) |
Grieving counselling NOS |
Grieving counselling |
slibning - handling |
Abrasion - action |
mikrokrystallinsk griseofulvin, 125 mg/5 mL suspension |
Product containing precisely griseofulvin 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Griseofulvin, microsize 125mg/mL suspension |
Product containing precisely griseofulvin 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Groin flap |
Flap (substance) |
Gross pathology NOS |
Gross pathology |
Gross pathology NOS |
Gross pathology request |
Gross stress reaction |
Acute stress disorder |
Væksthormonudløsningsfaktor-secernerende tumor |
Growth hormone releasing factor-secreting tumor of pancreas |
Guaiac test |
Chemical test for occult blood |
guaifenesin 50 mg + oxtriphyllin 100 mg eliksir |
Product containing only guaifenesin and theophylline in oral dose form (medicinal product form) |
guaifenesin 100 mg + theophyllinnatriumglycinat 300 mg eliksir |
Product containing only guaifenesin and theophylline in oral dose form (medicinal product form) |
guaifenesin 100 mg/5 ml syrup |
Product containing precisely guaifenesin 20 milligram/1 milliliter conventional release oral solution (clinical drug) |
Guaifenesin 1200mg /dextromethorphan 60mg prolonged-release oral tablet |
Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet |
Guaifenesin 1200mg /pseudoephedrine 120mg prolonged-release oral tablet |
Product containing precisely guaifenesin 1.2 gram and pseudoephedrine hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug) |
guaifenesin 1200 mg tablet med modificeret udløsning |
Product containing only guaifenesin in oral dose form (medicinal product form) |
guaifenesin 1200 mg med modificeret udløsning/dextromethorphan 60 mg tablet |
Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet |
guaifenesin 1200 mg + pseudoephedrin 120 mg tablet med modificeret udløsning |
Product containing precisely guaifenesin 1.2 gram and pseudoephedrine hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug) |
Guaifenesin 1200mg prolonged-release oral tablet |
Product containing only guaifenesin in oral dose form (medicinal product form) |
guaifenesin kapsel med modificeret udløsning a 300 mg |
Product containing only guaifenesin in oral dose form (medicinal product form) |
Guaifenesin 300mg prolonged-release oral capsule |
Product containing only guaifenesin in oral dose form (medicinal product form) |
guaifenesin 50 mg/1 ml |
Product containing only guaifenesin (medicinal product) |
Guaifenesin 600mg /dextromethorphan 30mg prolonged-release oral tablet |
Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) |
Guaifenesin 600mg /pseudoephedrine 60mg prolonged-release oral tablet |
Product containing precisely guaifenesin 600 milligram and pseudoephedrine hydrochloride 60 milligram/1 each prolonged-release oral tablet (clinical drug) |
guaifenesin kapsel med modificeret udløsning a 600 mg |
Product containing only guaifenesin in oral dose form (medicinal product form) |
guaifenesin 600 mg med modificeret udløsning/dextromethorphan 30 mg tablet |
Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) |
guaifenesin 600 mg med modificeret udløsning/pseudoephedrin 60 mg tablet |
Product containing precisely guaifenesin 600 milligram and pseudoephedrine hydrochloride 60 milligram/1 each prolonged-release oral tablet (clinical drug) |
Guaifenesin 600mg prolonged-release oral capsule |
Product containing only guaifenesin in oral dose form (medicinal product form) |
guanethidinmonosulfat 0,25 % øjendråber |
Product containing precisely guanethidine 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
guanethidinmonosulfat 0,5 % øjendråber |
Guanethidine 5 mg/mL eye solution |
guanethidinmonosulfat 1 % øjendråber |
Product containing precisely guanethidine 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
guanethidinmonosulfat 2 % øjendråber |
Product containing precisely guanethidine 20 milligram/1 milliliter conventional release eye solution (clinical drug) |
guanethidinmonosulfat 3 % øjendråber |
Product containing precisely guanethidine 30 milligram/1 milliliter conventional release eye solution (clinical drug) |
guanethidinmonosulfat 0,25 % + adrenalin 0,05 % øjendråber |
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution |
guanethidinmonosulfat 0,5 % + adrenalin 0,1 % øjendråber |
Adrenaline (as adrenaline acid tartrate) 1 mg/mL and guanethidine 5 mg/mL eye solution |
guanethidinmonosulfat 1 % + adrenalin 0,5 % øjendråber |
Adrenaline (as adrenaline acid tartrate) 5 mg/mL and guanethidine 10 mg/mL eye solution |
Guanfacine hydrochloride 1.0mg tablet |
Guanfacine (as guanfacine hydrochloride) 1 mg oral tablet |
Guanfacine hydrochloride 1mg extended release tablet |
Product containing precisely guanfacine (as guanfacine hydrochloride) 1 milligram/1 each prolonged-release oral tablet (clinical drug) |
Guanfacine hydrochloride 2mg extended release tablet |
Product containing precisely guanfacine (as guanfacine hydrochloride) 2 milligram/1 each prolonged-release oral tablet (clinical drug) |
Guanfacine hydrochloride 3mg extended release tablet |
Product containing precisely guanfacine (as guanfacine hydrochloride) 3 milligram/1 each prolonged-release oral tablet (clinical drug) |
Guanfacine hydrochloride 4mg extended release tablet |
Guanfacine (as guanfacine hydrochloride) 4 mg prolonged-release oral tablet |
Guide wire placement via previous catheter |
To put in between or into a part(s) of the body. |
Gummata of yaws |
Nodular late yaws |
Gummatous frambeside |
Nodular late yaws |
krudt |
Gunpowder (substance) |
Gunstock deformity |
Acquired cubitus varus |
midlertidigt Gunther-vena cava-filter |
Temporary vena cava filter |
Gynaecological disorder monitoring NOS |
Gynaecological disorder monitoring |
Gynaecological history NOS |
Gynaecological history |
Gynecological disorder monitoring NOS |
Gynaecological disorder monitoring |
Gynecological history NOS |
Gynaecological history |
Gynækologisk laparoskopi, ikke klassificeret andetsteds |
Laparoscopy |
H/O: CNS disorder NOS |
H/O: CNS disorder |
H/O: GIT disease NOS |
H/O: gastrointestinal disease |
H/O: GIT haemorrhage (& [NOS]) |
History of gastrointestinal bleed |
H/O: GIT haemorrhage NOS |
History of gastrointestinal bleed |
H/O: anaemia NOS |
History of anemia (situation) |
H/O: anaesthetic allergy |
Allergy to drug |
H/O: analgesic allergy |
Allergy to drug |
H/O: antibiotic allergy NOS |
Allergy to drug |
H/O: artificial opening NOS |
History of surgery (situation) |
H/O: artificial tissue NOS |
History of artificial organ or tissue (situation) |
H/O: blood disorder NOS |
H/O: blood disorder |
H/O: cat allergy |
Allergy to Felis catus protein (finding) |
H/O: cat allergy |
Allergy to Felis catus protein (finding) |
H/O: congenital anomaly NOS |
H/O: congenital anomaly |
H/O: drug abuse |
History of substance use disorder (situation) |
H/O: drug allergy NOS |
Allergy to drug |
H/O: drug dependency |
History of substance dependency (situation) |
H/O: ear disorder NOS |
H/O: ear disorder |
H/O: endocrine disorder NOS |
H/O: endocrine disorder |
H/O: heart disease NOS |
H/O: heart disorder |
H/O: high risk medication NOS |
H/O: high risk medication |
H/O: infectious disease NOS |
H/O: infectious disease |
H/O: injury NOS |
History of injury (situation) |
H/O: machine dependence NOS |
H/O: machine dependence |
H/O: male genital disorder NOS |
H/O: male genital disorder |
H/O: medical history NOS |
History of clinical finding in subject (situation) |
H/O: medical history NOS |
History of clinical finding in subject (situation) |